Mackenzie Financial’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $90.6M | Buy |
234,240
+161,297
| +221% | +$59.8M | 0.09% | 181 |
|
|
2026
Q1 | $21.4M | Sell |
72,943
-8,189
| -10% | -$2.69M | 0.03% | 403 |
|
|
2025
Q4 | $28.2M | Sell |
81,132
-202
| -0.2% | -$68.3K | 0.03% | 339 |
|
|
2025
Q3 | $26.3M | Buy |
81,334
+8,297
| +11% | +$2.58M | 0.03% | 342 |
|
|
2025
Q2 | $28.4M | Buy |
73,037
+21,193
| +41% | +$8.52M | 0.04% | 306 |
|
|
2025
Q1 | $22.6M | Buy |
51,844
+2,538
| +5% | +$1.02M | 0.03% | 321 |
|
|
2024
Q4 | $18.2M | Sell |
49,306
-29,871
| -38% | -$12.5M | 0.02% | 367 |
|
|
2024
Q3 | $41.2M | Buy |
79,177
+5,213
| +7% | +$2.78M | 0.06% | 243 |
|
|
2024
Q2 | $40.1M | Buy |
73,964
+773
| +1% | +$409K | 0.06% | 243 |
|
|
2024
Q1 | $38M | Sell |
73,191
-16,234
| -18% | -$8.07M | 0.05% | 249 |
|
|
2023
Q4 | $42.2M | Sell |
89,425
-9,360
| -9% | -$4.33M | 0.06% | 233 |
|
|
2023
Q3 | $42.8M | Sell |
98,785
-10,501
| -10% | -$4.76M | 0.07% | 215 |
|
|
2023
Q2 | $48.6M | Sell |
109,286
-4,312
| -4% | -$1.99M | 0.07% | 214 |
|
|
2023
Q1 | $52.2M | Sell |
113,598
-13,048
| -10% | -$6.21M | 0.08% | 217 |
|
|
2022
Q4 | $65M | Sell |
126,646
-28,193
| -18% | -$14.3M | 0.11% | 176 |
|
|
2022
Q3 | $70.3M | Buy |
154,839
+17,868
| +13% | +$8.55M | 0.12% | 172 |
|
|
2022
Q2 | $66.1M | Sell |
136,971
-25,598
| -16% | -$12.7M | 0.11% | 185 |
|
|
2022
Q1 | $79.9M | Sell |
162,569
-5,649
| -3% | -$2.58M | 0.11% | 182 |
|
|
2021
Q4 | $78M | Sell |
168,218
-8,258
| -5% | -$3.47M | 0.11% | 190 |
|
|
2021
Q3 | $65.8M | Sell |
176,476
-5,146
| -3% | -$1.96M | 0.09% | 201 |
|
|
2021
Q2 | $69.3M | Buy |
181,622
+55,180
| +44% | +$21.1M | 0.1% | 198 |
|
|
2021
Q1 | $45.4M | Buy |
126,442
+33,244
| +36% | +$10.7M | 0.07% | 216 |
|
|
2020
Q4 | $29.9M | Buy |
93,198
+19,307
| +26% | +$5.93M | 0.06% | 220 |
|
|
2020
Q3 | $19.8M | Buy |
73,891
+22,180
| +43% | +$5.97M | 0.05% | 233 |
|
|
2020
Q2 | $13.6M | Buy |
51,711
+34,012
| +192% | +$9.07M | 0.04% | 266 |
|
|
2020
Q1 | $4.02M | Buy |
17,699
+391
| +2% | +$107K | 0.01% | 369 |
|
|
2019
Q4 | $5.23M | Sell |
17,308
-9,120
| -35% | -$2.51M | 0.01% | 425 |
|
|
2019
Q3 | $6.34M | Sell |
26,428
-3,932
| -13% | -$1.08M | 0.02% | 397 |
|
|
2019
Q2 | $8.57M | Sell |
30,360
-18,589
| -38% | -$5.08M | 0.02% | 338 |
|
|
2019
Q1 | $14M | Sell |
48,949
-177,395
| -78% | -$51.3M | 0.03% | 323 |
|
|
2018
Q4 | $59.4M | Sell |
226,344
-70,139
| -24% | -$19.3M | 0.16% | 137 |
|
|
2018
Q3 | $81.3M | Buy |
296,483
+110,110
| +59% | +$28.6M | 0.2% | 127 |
|
|
2018
Q2 | $44.4M | Buy |
186,373
+121,357
| +187% | +$28.1M | 0.11% | 178 |
|
|
2018
Q1 | $14.3M | Sell |
65,016
-57,787
| -47% | -$13.6M | 0.04% | 278 |
|
|
2017
Q4 | $27.6M | Buy |
122,803
+25,299
| +26% | +$5.39M | 0.07% | 223 |
|
|
2017
Q3 | $18.5M | Buy |
97,504
+66,683
| +216% | +$12.7M | 0.1% | 190 |
|
|
2017
Q2 | $5.8M | Buy |
30,821
+146
| +0.5% | +$26.2K | 0.03% | 299 |
|
|
2017
Q1 | $5.07M | Sell |
30,675
-6,176
| -17% | -$982K | 0.03% | 300 |
|
|
2016
Q4 | $5.3M | Buy |
36,851
+22,217
| +152% | +$2.97M | 0.03% | 271 |
|
|
2016
Q3 | $1.83M | Sell |
14,634
-39,723
| -73% | -$5.13M | 0.01% | 343 |
|
|
2016
Q2 | $7.14M | Buy |
54,357
+11,677
| +27% | +$1.6M | 0.04% | 285 |
|
|
2016
Q1 | $5.93M | Buy |
42,680
+28,760
| +207% | +$3.84M | 0.05% | 247 |
|
|
2015
Q4 | $1.94M | Buy |
13,920
+2,362
| +20% | +$325K | 0.01% | 420 |
|
|
2015
Q3 | $1.62M | Sell |
11,558
-2,568
| -18% | -$386K | 0.01% | 450 |
|
|
2015
Q2 | $2.32M | Buy |
14,126
+3,893
| +38% | +$622K | 0.01% | 409 |
|
|
2015
Q1 | $1.58M | Buy |
10,233
+2,078
| +25% | +$296K | 0.01% | 469 |
|
|
2014
Q4 | $1.02M | Buy |
8,155
+2,575
| +46% | +$318K | 0.01% | 529 |
|
|
2014
Q3 | $667K | Buy |
5,580
+545
| +11% | +$62.5K | ﹤0.01% | 578 |
|
|
2014
Q2 | $542K | Buy |
5,035
+954
| +23% | +$98.3K | ﹤0.01% | 582 |
|
|
2014
Q1 | $406K | Buy |
4,081
+854
| +26% | +$77.2K | ﹤0.01% | 601 |
|
|
2013
Q4 | $298K | Buy |
+3,227
| New | +$287K | ﹤0.01% | 607 |
|
Other funds holding ELV
Mackenzie Financial's ELV Position: Q2 2026 in Review
Mackenzie Financial increased its Elevance Health (ELV) stake by 221% in Q2 2026, buying an estimated $59.8M and bringing the position to 234,240 shares worth $90.6M. The position accounts for 0.09% of the portfolio, ranked #181.
Mackenzie Financial first reported a position in ELV in Q4 2013 and has held it in 51 quarters since. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Mackenzie Financial held 234,240 shares of Elevance Health worth $90.6M as of Q2 2026.
- Mackenzie Financial bought 161,297 Elevance Health shares in Q2 2026, an estimated $59.8M.
- Elevance Health made up 0.09% of Mackenzie Financial's portfolio in Q2 2026, its #181 holding.
- Mackenzie Financial first reported a position in Elevance Health in Q4 2013 and has held it in 51 quarters since.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.